Replies to post #97081 on Biotech Values

[DewDiligence]

MNTA TEVA:

…was there anything mentioned at the meeting relative to lovenox on either TEVA's chances of approval or substitutability of either the MNTA or TEVA version?

No one at the meeting opined with respect to Teva’s chances of FDA approval for Lovenox as either a substitutable generic or a non-substitutable product. MNTA’s position has always been that its own generic Lovenox will be a substitutable generic. Regards, Dew